The DOI matches its Crossref record; 78 of the 86 references it cites were found in a registry or an index.
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Open accessAbstract
Chk2/hcds1, the human homolog of the Saccharomyces cerevisiae RAD53/SPK1 and Schizosaccharomyces pombe cds1 DNA damage checkpoint genes, encodes a protein kinase that is post-translationally modified after DNA damage. Like its yeast homologs, the Chk2/hCds1 protein phosphorylates Cdc25C in vitro, suggesting that it arrests cells in G 2 in response to DNA damage. We expressed Chk2/hCds1 in human cells and analyzed their cell cycle profile. Wild-type, but not catalytically inactive, Chk2/hCds1 led to G 1 arrest after DNA damage. The arrest was inhibited by cotransfection of a dominant-negative p53 mutant, indicating that Chk2/hCds1 acted upstream of p53. In vitro, Chk2/hCds1 phosphorylated p53 on Ser-20 and dissociated preformed complexes of p53 with Mdm2, a protein that targets p53 for degradation. In vivo, ectopic expression of wild-type Chk2/hCds1 led to increased p53 stabilization after DNA damage, whereas expression of a dominant-negative Chk2/hCds1 mutant abrogated both phosphorylation of p53 on Ser-20 and p53 stabilization. Thus, in response to DNA damage, Chk2/hCds1 stabilizes the p53 tumor suppressor protein leading to cell cycle arrest in G 1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and hChk2, in turn, phosphorylates yet another amino-terminal Ser residue (Ser 20) in p53”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Chehab et al. 2000
In the citing paper
“These phosphorylation events contribute to disrupting the p53-Mdm2 (Chehab et al., 2000; Shieh et al., 2000), and Mdm2-DAXX (Tang et al., 2013) interactions, as well as to the degradation of Mdm2 and Mdm4 (Stommel and Wahl, 2004; Chen et al., 2005; Pereg et al., 2005, 2006; LeBron et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Chehab et al., 2000
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“Studies using Chk2-null mice, Chk2-null HCT116 cells, and Chk2 siRNA resulted in different conclusions (Zhang et al, 1998;Chehab et al, 2000;Shieh et al, 2000;Ahn et al, 2003; Jallepalli et al, 2003).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“Although a role of ATM in p53 response is well established, the significance of Chk2 is still a matter of debate.”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Chehab et al, 2000
In the citing paper
“p53 is phosphorylated at Ser20 by the checkpoint kinase Chk2 after IR, which results in p53's dissociation from Mdm2 and its subsequent stabilization”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Chehab et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“Stabilization of p53 in cells exposed to IR or UV light is due to dissociation from Mdm2 (Shieh et al. 1997), a protein that targets p53 for degradation through the ubiquitin pathway (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Flagged first, then by citations
8 of the 86 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 805
ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress
Pauklin, S., Kristjuhan, A., Maimets, T., & Jaks, V. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.097 · Cited by 69
Autophosphorylation of Checkpoint Kinase 2 at Serine 516 Is Required for Radiation-induced Apoptosis
Wu, X., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303795200 · Cited by 70
Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage
Stracker, T. H., Couto, S. S., Cordon‐Cardo, C., Matos, T., & Petrini, J. H. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.028 · Cited by 64
Stewart, Z. A., Tang, L. J., & Pietenpol, J. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204060 · Cited by 68
The end protection problem—an unexpected twist in the tail
Ruis, P., & Boulton, S. J. (2021) · Genes & Development · doi:10.1101/gad.344044.120 · Cited by 57
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling
Sablina, A. A., Chumakov, P. M., Levine, A. J., & Kopnin, B. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204156 · Cited by 68
Collaboration of Brca1 and Chk2 in tumorigenesisPreprint
McPherson, J. P., Lemmers, B., Hirao, A., Hakem, A., Abraham, J., Migon, E., Matysiak‐Zablocki, E., Tamblyn, L., Sanchez-Sweatman, O. H., Khokha, R., et al. (2004) · Genes & Development · doi:10.1101/gad.1192704 · Cited by 67
Goudelock, D. M., Jiang, K., Pereira, E., Russell, B., & Sánchez, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301765200 · Cited by 69
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
Matin, R., Chikh, A., Chong, S. L. P., Mesher, D., Graf, M., Sanzà, P., Senatore, V., Scatolini, M., Moretti, F., Leigh, I. M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121439 · Cited by 66
Lee, J. H., Xu, B., Lee, C. H., Ahn, J.-Y., Song, M. S., Lee, H., Canman, C. E., Lee, J., Kastan, M. B., & Lim, D. (2003) · PubMed · Cited by 65
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
Ingvarsson, S., Sigbjornsdottir, B. I., Huiping, C., Hafsteinsdottir, S. H., Ragnarsson, G., Barkardottir, R. B., Arason, A., Egilsson, V., & Bergthorsson, J. T. (2002) · Breast Cancer Research · doi:10.1186/bcr435 · Cited by 63
Polo-like kinase-1 in DNA damage response
Hyun, S., Hwan, H.-I., & Jang, Y. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.5.061 · Cited by 66
CHEK2 1100delC is not a risk factor for male breast cancer population
Syrjäkoski, K., Kuukasjärvi, T., Auvinen, A. P., & Kallioniemi, O. (2003) · International Journal of Cancer · doi:10.1002/ijc.11384 · Cited by 63
McDonald, E. R., & El‐Deiry, W. S. (2001) · Annals of Medicine · doi:10.3109/07853890109002066 · Cited by 64
Jang, S. H., Lim, J. W., Morio, T., & Kim, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.010 · Cited by 62
EDD Mediates DNA Damage-induced Activation of CHK2
Henderson, M. J., Munoz, M. A., Saunders, D. N., Clancy, J. L., Russell, A. J., Williams, B. L., Pappin, D., Khanna, K. K., Jackson, S. P., Sutherland, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602818200 · Cited by 64
DAWDLE , a Forkhead-Associated Domain Gene, Regulates Multiple Aspects of Plant Development
Morris, E. R., Chevalier, D., & Walker, J. C. (2006) · PLANT PHYSIOLOGY · doi:10.1104/pp.106.076893 · Cited by 62
A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression
Wang, Y., Huang, J., Li, B., Han, X., Tricot, G. J. K., Hu, L., Xu, Z., Sun, X., Chang, S., Gao, L., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3987 · Cited by 62
Bean, L. J., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204204 · Cited by 63
CYTOLETHAL DISTENDING TOXIN (CDT): GENETIC DIVERSITY, STRUCTURE AND ROLE IN DIARRHEAL DISEASE
Yamasaki, S., Asakura, M., Tsukamoto, T., Faruque, S. M., Deb, R., & Ramamurthy, T. (2006) · Toxin Reviews · doi:10.1080/15569540500320938 · Cited by 61
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022) · Oncogene · doi:10.1038/s41388-022-02331-9 · Cited by 60
van Leeuwen, L. A. G., & Hoozemans, J. J. M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1382-7 · Cited by 64
STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage
Townsend, P. A., Cragg, M. S., Davidson, S. M., McCormick, J., Barry, S. P., Lawrence, K. M., Knight, R. A., Hubank, M. J. F., Chen, P., Latchman, D. S., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01728 · Cited by 62
RetractedBahassi, E. M., Myer, D. L., McKenney, R. J., Hennigan, R. F., & Stambrook, P. J. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.12.002 · Cited by 60
Hofmann, W., Miller, C. W., Tsukasaki, K., Tavor, S., Ikezoe, T., Hoelzer, D. F., Takeuchi, S., & Koeffler, H. P. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00130-2 · Cited by 60
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 59
Zimmermann, M., Don, A. S. A., Donaldson, M. S., Dallapiazza, R. F., Cowan, C. E., & Horne, M. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376855 · Cited by 63
Activation of ATM and phosphorylation of p53 by heat shock
Miyakoda, M., Suzuki, K., Kodama, S., & Watanabe, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205196 · Cited by 59
Siu, W. Y., Lau, A. W. S., Arooz, T., Chow, J. P. H., Ho, H. T. B., & Poon, R. Y. C. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.621.3.5 · Cited by 59
Wang, Z., Yang, K., Zheng, Q., Zhang, C., Tang, H., Babicheva, A., Jiang, Q., Li, M., Chen, Y., Carr, S. G., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00538.2017 · Cited by 58
The EBNA- 3 gene family proteins disrupt the G2/M checkpoint
Krauer, K. G., Burgess, A., Buck, M., Flanagan, J. M., Sculley, T. B., & Gabrielli, B. G. (2003) · Oncogene · doi:10.1038/sj.onc.1207253 · Cited by 59
Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways
Blaydes, J. P., Craig, A. L., Wallace, M., Ball, H. M.-L., Traynor, N. J., Gibbs, N. K., & Hupp, T. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203773 · Cited by 60
Maintenance of imaginal disc plasticity and regenerative potential in Drosophila by p53
Wells, B. S., & Johnston, L. A. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.012 · Cited by 62
Lu, X., Magrane, G., Yin, C., Louis, D. N., Gray, J. W., & Dyke, T. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.6017-6030.2001 · Cited by 55
Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer.
Matsuoka, S., Nakagawa, T., Masuda, A., Haruki, N., Elledge, S. J., & Takahashi, T. (2001) · PubMed · Cited by 58
Replication licensing promotes cyclin D1 expression and G1progression in untransformed human cells
Liu, P., Slater, D., Lenburg, M. E., Nevis, K. R., Cook, J. G., & Vaziri, C. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7528 · Cited by 57
Ismail, I. A., Kang, K.-S., Lee, H. A., Kim, J.-W., & Sohn, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.039 · Cited by 56
Mechanism study of goldenseal-associated DNA damage
Chen, S., Wan, L., Couch, L. H., Lin, H., Li, Y., Dobrovolsky, V. N., Mei, N., & Guo, L. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.05.641 · Cited by 56
Splicing DNA-damage responses to tumour cell death
Crighton, D., & Ryan, K. M. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.001 · Cited by 56
Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells
Chattopadhyay, D., Ghosh, M. K., Mal, A. K., & Harter, M. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9844-9856.2001 · Cited by 55
Levav-Cohen, Y., Goldberg, Z., Zuckerman, V., Grossman, T., Haupt, S., & Haupt, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.152 · Cited by 57
The role of DNA damage and repair in atherosclerosis: A review
Shah, N. R., & Mahmoudi, M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.07.005 · Cited by 56
Nakanishi, M., Ozaki, T., Yamamoto, H., Hanamoto, T., Kikuchi, H., Furuya, K., Asaka, M., Delia, D., & Nakagawara, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611412200 · Cited by 56
Chernov, M. V., Bean, L. J., Lerner, N., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103170200 · Cited by 55
Cell Cycle Checkpoint Control Mechanisms That Can Be Disrupted in Cancer
Dash, B. C., & El‐Deiry, W. S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:099 · Cited by 55
Pharmacological Inhibition of the DNA Damage Checkpoint Prevents Radiation-Induced Oocyte Death
Rinaldi, V. D., Hsieh, K., Munroe, R., Bolcun‐Filas, E., & Schimenti, J. C. (2017) · Genetics · doi:10.1534/genetics.117.203455 · Cited by 54
Robust G1 checkpoint arrest in budding yeast: dependence on DNA damage signaling and repair
Gerald, J. N. F., Benjamin, J. M., & Kron, S. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.8.1749 · Cited by 54
Stavridi, E. S., Chehab, N. H., Malikzay, A., & Halazonetis, T. D. (2001) · PubMed · Cited by 54
Self-citationATM dependent apoptosis in the nervous system
Lee, Y., & McKinnon, P. J. (2000) · APOPTOSIS · doi:10.1023/a:1009637512917 · Cited by 53
Jabbur, J. R., Huang, P., & Zhang, W. (2000) · Oncogene · doi:10.1038/sj.onc.1204017 · Cited by 60
Halazonetis, T. D. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.036 · Cited by 53
Self-citationDetermination of substrate specificity and putative substrates of Chk2 kinase
Seo, G., Kim, S.-E., Lee, Y.-M., Lee, J., Lee, J.-R., Hahn, M., & Kim, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00589-8 · Cited by 55
Ostrakhovitch, E. A., & Cherian, M. G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.01.004 · Cited by 53
Protein kinases and their involvement in the cellular responses to genotoxic stress
Yang, J. J., Yu, Y., & Duerksen-Hughes, P. J. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00069-8 · Cited by 53
CHEK2 variants: linking functional impact to cancer risk
Boonen, R. A. C. M., Vreeswijk, M. P. G., & van Attikum, H. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.04.009 · Cited by 54
p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma
Rassidakis, G. Z., Thomaides, A. X., Wang, S., Jiang, Y., Fourtouna, A., Lai, R., & Medeiros, L. J. (2005) · Leukemia · doi:10.1038/sj.leu.2403840 · Cited by 56
Liu, D., Cui, L., Wang, Y., Yang, G., He, J., Hao, R., Fan, C., Qu, M., Liu, Z., Wang, M., et al. (2016) · Hepatology · doi:10.1002/hep.28594 · Cited by 54
A new effector pathway links ATM kinase with the DNA damage response
Demonacos, C., Krstic–Demonacos, M., Smith, L. M., Xu, D., O’Connor, D. P., Jansson, M., & Thangue, N. B. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1170 · Cited by 53
Molecular Anatomy of the DNA Damage and Replication Checkpoints
Qin, J., & Li, L. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0139:maotdd]2.0.co;2 · Cited by 52
Gueven, N., Keating, K. E., Chen, P., Fukao, T., Khanna, K. K., Watters, D. J., Rodemann, H. P., & Lavin, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006190200 · Cited by 51
Maas, K. H., Westfall, M. D., Pietenpol, J. A., Olsen, N. J., & Aune, T. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20931 · Cited by 51
Chen, C.-R., Wang, W., Rogoff, H. A., Li, X., Mang, W., & Li, C. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0677 · Cited by 52
Breast Cancer Susceptibility and the DNA Damage Response
Đapic, V., Carvalho, M. A., & Monteiro, Á. N. A. (2005) · Cancer Control · doi:10.1177/107327480501200210 · Cited by 49
Sidorova, J. M., & Breeden, L. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3405-3416.2003 · Cited by 51
Chow, J. P. H., Siu, W. Y., Fung, T. K., Chan, W. M., Lau, A. W. S., Arooz, T., Ng, C.-P., Yamashita, K., & Poon, R. Y. C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0168 · Cited by 51
The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression
Roche, K. C., Wiechens, N., Owen‐Hughes, T., & Perkins, N. D. (2004) · Oncogene · doi:10.1038/sj.onc.1208025 · Cited by 48
The Werner syndrome protein contributes to induction of p53 by DNA damage
Blander, G., Zalle, N., Martínez-Leal, J. F., Bar‐Or, R. L., Yu, C., & Oren, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0171fje · Cited by 49
BRCT domains: A little more than kin, and less than kind
Gerloff, D. L., Woods, N. T., Farago, A. A., & Monteiro, Á. N. A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.005 · Cited by 51
Cell cycle control, DNA damage checkpoints and cancer
Laiho, M., & Latonen, L. (2003) · Annals of Medicine · doi:10.1080/07853890310014605 · Cited by 51
Sohn, T. A., Bansal, R. K., Su, G. H., Murphy, K. M., & Kern, S. E. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.949 · Cited by 49
Casein Kinase 1α Regulates an MDMX Intramolecular Interaction To Stimulate p53 Binding
Wu, S., Chen, L., Becker, A., Schönbrunn, E., & Chen, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00851-12 · Cited by 48
Early Events in the DNA Damage Response
Ward, I. M., & Chen, J. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63001-8 · Cited by 50
p53 protects from replication-associated DNA double-strand breaks in mammalian cells
Kumari, A. R., Schultz, N., & Helleday, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207379 · Cited by 48
Yoda, A., Xu, X. Z., Onishi, N., Toyoshima, K., Fujimoto, H., Kato, N., Oishi, I., Kondo, T., & Minami, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600403200 · Cited by 48
Murine Protein Serine-threonine Kinase 38 Activates p53 Function through Ser15 Phosphorylation
Seong, H., & Ha, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347757 · Cited by 48
Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47
Posttranslational phosphorylation of mutant p53 protein in tumor development
Matsumoto, M., Furihata, M., & Ohtsuki, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0320-0 · Cited by 47
ROS-mediated apoptosis of HAPI microglia through p53 signaling following PFOS exposure
Ge, J., Wang, C., Nie, X., Yang, J., Lu, H., Song, X., Su, K., Li, T., Han, J., Zhang, Y., et al. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.06.025 · Cited by 47
Selimović, D., Ahmad, M., El‐Khattouti, A., Hannig, M., Haïkel, Y., & Hassan, M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr112 · Cited by 45
Pluquet, O., North, S., Bhoumik, A., DIMAS, K. S., Ronai, Z. A., & Hainaut, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207396200 · Cited by 45
Jabbur, J. R., Tabor, A., Cheng, X., Wang, H., Uesugi, M., Lozano, G., & Zhang, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205856 · Cited by 46
Hepatitis C Virus NS2 Protein Inhibits DNA Damage Pathway by Sequestering p53 to the Cytoplasm
Bittar, C., Shrivastava, S., Chowdhury, J. B., Rahal, P., & Ray, R. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062581 · Cited by 44
The switch from survival responses to apoptosis after chromosomal breaks
Bree, R. T., Neary, C. L., Samali, A., & Lowndes, N. F. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.016 · Cited by 43
Tse, A. N., Sheikh, T. N., Ho, A. L., Chou, T., & Schwartz, G. K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050807 · Cited by 43
ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
Wang, J., Wiltshire, T. D., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Laar, E. S. V., Waters, S. J., Reed, E., & Wang, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400015200 · Cited by 44
DisruptingTP53 in mouse models of human cancers
Parant, J. M., & Lozano, G. (2003) · Human Mutation · doi:10.1002/humu.10186 · Cited by 47
NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway
Wilson, K. A., & Stern, D. F. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7102 · Cited by 43
Less-well known functions of cyclin/CDK complexes
Palmer, N., & Kaldis, P. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.003 · Cited by 44
Zhou, J., Lim, C. U. K., Li, J. J., Cai, L., & Zhang, Y. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.026 · Cited by 45
Haneda, M., Kojima, E., Nishikimi, A., Hasegawa, T., Nakashima, I., & Isobe, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.066 · Cited by 46
kConFab Investigators, Jekimovs, C., Chen, X., Arnold, J. M., Gatei, M. H., Richard, D. J., Spurdle, A. B., Khanna, K. K., & Chenevix‐Trench, G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602381 · Cited by 43
p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function
Zeng, X., Lee, H., Zhang, Q., & Lu, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000722200 · Cited by 46
TP53, hChk2, and the Li-Fraumeni Syndrome
Varley, J. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:117 · Cited by 43
ATM and Genome Maintenance: Defining Its Role in Breast Cancer Susceptibility
Khanna, K. K., & Chenevix‐Trench, G. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048772.92326.a1 · Cited by 43
Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions
Bahassi, E. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011011 · Cited by 42
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer
Bártková, J., Guldberg, P., Grønbæk, K., Koed, K., Primdahl, H., Møller, K., Lukas, J., Orntoft, T. F., & Bártek, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207878 · Cited by 43
Wang, H., Wang, X., Iliakis, G. E., & Wang, Y. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0420:ccnesh]2.0.co;2 · Cited by 42
The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma
Hahm, E., Jin, D., Kang, J. S., Kim, Y., Hong, S., Lee, S. K., Kim, H., Jung, D. J., Kim, J. E., Shin, D. H., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21336 · Cited by 42
Zhang, Z., Ferraris, J. D., Irarrázabal, C. E., Dmitrieva, N. I., Park, J., & Burg, M. B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00417.2004 · Cited by 41
Regulation of Chk2 Ubiquitination and Signaling through Autophosphorylation of Serine 379
Lovly, C. M., Yan, L., Ryan, C. E., Takada, S., & Piwnica-Worms, H. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-08 · Cited by 42
Metadata
- Authors
- Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D.
- Affiliations
- The Wistar Institute (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-02-01
- Volume
- 14
- Issue
- 3
- Pages
- 278-288
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316357
- OpenAlex
- W2131833681
- Cited by
- 805
- References
- 86
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 19 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 25 · 2015: 16 · 2014: 28 · 2013: 27 · 2012: 29
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health (CA-25874)
- National Cancer Institute (CA09171, CA-25874, CA-76367, R01CA076367, P01CA025874, T32CA009171)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Chk2, DNA damage checkpoint, p53 stabilization, MDM2, G1 cell cycle arrest, Cdc25C phosphorylation, post-translational modification, tumor suppressor proteins, dominant-negative mutant
- MeSH terms
- DNA Damage, Humans, Nuclear Proteins, Phosphorylation, Protein Kinases, Proto-Oncogene Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, G1 Phase, Protein Serine-Threonine Kinases, Schizosaccharomyces pombe Proteins, Proto-Oncogene Proteins c-mdm2, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
